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Received July 13, 2011; accepted December 14, 2011AbstractBackground: This study investigated the impact of hospice care on end-of-life elderly patients with lung cancer in Taiwan.
Methods: Data were collected from deceased inpatients with lung cancer who were at least 65 years old, using the National Health Insurance
Research Database of 2004.
Results: A total of 1282 patients were enrolled, of whom 277 (21.6%) received hospice care (hospice-care group) and the other 1005 (78.4%)
received general acute ward care (control group). The patients’ age, gender, and institution of hospitalization did not differ significantly between
the two groups, and most of the patients had chosen medical centers and their affiliated hospices for terminal care. The hospice-care group had
a significantly shorter hospital stay and lower costs of hospitalization than the control group, with patients cared for primarily by family
physicians and radiation oncologists (all p< 0.05). The hospice-care group had an elevated incidence of co-morbid diabetes mellitus, higher
scores on the Charlson Comorbidity Index, fewer acute lower respiratory conditions, and fewer invasive procedures than the control group
(all p< 0.05). Natural opium alkaloids were the most commonly prescribed drugs in the hospice-care group, whereas parenteral solutions were
most frequently requested in the control group.
Conclusion: Hospice care has provided a humane and cost-efficient pathway for end-of-life elderly patients with lung cancer. Parenteral
nutrition/hydration should be limited for terminal care patients. Opioids should be promoted for the relief of pain and dyspnea in acute ward care.
Family physicians and radiation oncologists play important roles in hospice care. Compared with the prevalence of hospice care in the United
Kingdom and other developed countries, hospice care in Taiwan is in the position to be expanded.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
Keywords: aged; family practice; hospice care; lung neoplasms; radiation oncology1. Introduction
Hospice care, also known as palliative care, started in the
United Kingdom over 30 years ago and has expanded world-
wide. In the West, palliative care has developed to serve all
types of terminal patients, not only those with advanced* Corresponding author. Dr. Shinn-Jang Hwang, Department of Family
Medicine, Taipei Veterans General Hospital, 201 Section 2 Shih-Pai Road,
Taipei 112, Taiwan, ROC.
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doi:10.1016/j.jcma.2012.04.005cancer, as in the Liverpool Care Pathway and Palliative Care
for Advanced Diseases.1e3
In Taiwan, hospice care was introduced by local religious
hospitals in the mid-1980s,4 and has been legislated and
enrolled with the National Health Insurance (NHI) since 2000.
From September 2009, NHI has expanded the indications of
hospice care from patients with advanced cancer or amyo-
trophic lateral sclerosis to those with other terminal conditions
requiring comprehensive care.5
Lung cancer has been the primary cause of cancer deaths in
both genders in Taiwan over the past 20 years.6 Previoushinese Medical Association. All rights reserved.
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further confirm that patients with lung cancer accounted for
the majority of all patients in hospice care.4,7 However, the
impact of hospice care on patients with lung cancer remains
unclear, especially when elderly patients are involved. Based
on population-based dataset analyses, focussed on end-of-life
hospitalized elderly care cases, the aim of this study was to
extend our understanding of the aforementioned issues.
2. Methods2.1. Study designRetrospective and nested case-control analyses were per-
formed. End-of-life hospitalization data were collected,
focussing on deceased inpatients at least 65 years old with
lung cancer, taken from the National Health Insurance
Research Database (NHIRD) in 2004. In Taiwan, the NHI
(established in 1995) has accumulated voluminous nationwide
claim data. The NHIRD was established by National Health
Research Institute in 1998, and provides encrypted claim data
relating to NHI to local academic institutions for study.8 We
obtained the complete inpatient service claim datasets for
patients at least 65 years of age (DD2004.dat), with corre-
sponding prescription and ordering files (OO2004.dat) for the
year 2004. Data for deceased inpatients with a major diagnosis
of lung cancer were extracted using the International Classi-
fication of Diseases, the Ninth Revision Clinical Modification
(ICD-9-CM) code of 162. Patients with lung cancer who
received hospice care were listed as the hospice-care group.
Those who received other general acute ward care were listed
as the control group. Certain special conditions other than
hospice or acute ward care were excluded (Fig. 1).2.2. ParametersThe patients’ general data, co-morbidities and claims for
charges and prescriptions during their end-of-life hospitaliza-
tions were analyzed. The co-morbidities were defined andFig. 1. Design of the study for patients aged  65 years with lung canscreened using the relevant ICD-9-CM codes for the discharge
diagnosis of the patients. Co-morbidities, commonly seen in
the elderly, such as diabetes mellitus (ICD-9-CM code 250.x),
stroke (ICD-9-CM code 430.x-438.x), chronic obstructive
pulmonary disease (ICD-9-CM code 490.x -496.x), ischemic
heart disease (ICD-9-CM code 410.x-414.x), and acute lower
respiratory conditions (ICD-9-CM code 480.x-487.x) were
included. The patients’ severities of illness were presented and
compared using the Charlson Comorbidity Index.9 Drug
prescriptions were screened among the claimed orders during
the patients’ end-of-life hospitalizations, and were classified
by Anatomic Therapeutic Chemical (ATC) Classification
codes. Invasive procedures, in our study, included cardiopul-
monary resuscitations (CPR), defibrillation/cardioversion,
endotracheal intubations, tracheostomy, chest tapping/intuba-
tions, nasogastric intubations, urinary catheterizations, central
venous catheter insertions, hemodialysis, intensive care unit
(ICU) admission, and respirator care.
To protect our patients’ privacy, data identifying patients,
physicians, and institutions were cryptographically scrambled.
This study was approved by the Institutional Review Board of
National Yang-Ming University (IRB No. 990062).2.3. Statistical analysisData-mining and processing was conducted using the
Microsoft SQL Server (Microsoft Inc., Redmond, WA, USA).
Data in the text and tables are illustrated as mean standard
deviation. SPSS software (SPSS version 17.0, SPSS Inc.,
Chicago, IL, USA) was used for statistical analysis. The
independent t, Chi-square, trend Chi-square, and Fisher’s exact
tests were used to assess statistical significance. A p value of
< 0.05 was considered statistically significant (two-tailed
tests).
3. Results
During the study period, a total of 1282 patients were fitted
the criteria for the study design and were enrolled; 277cer dying in hospitals or hospices during 2004. TB¼ tuberculosis.
Table 1
The demographic characteristics and costs of end-of-life hospitalization in elderly lung cancer patients during 2004.
Parameters Hospice-care group (n¼ 277) Control group (n¼ 1005) pa
Age (y) 76.5 6.4 77.2 6.6 0.119
Gender (male/female) 204/73 775/230 0.232
Grade of hospitalization institutions
(medical centers/regional hospitals/local hospitals)
163/83/31 547/314/144 0.121
Hospital stay (d) 10.7 10.9 18.5 15.2 < 0.001
Daily charges of laboratory examinations (USD/d) 6.8 11.7 25.4 29.9 < 0.001
Daily charges of radiological examinations (USD/day) 4.0 12.7 15.2 34.6 < 0.001
Daily charges of drug prescriptions (USD/d) 27.1 27.0 54.5 61.0 < 0.001
Daily charges of hospitalization (USD/d) 145.9 18.4 226.5 186.3 < 0.001
Total charges of hospitalization (USD) 1564.2 1661.4 3864.6 4272.8 < 0.001
USD¼United States Dollar.
a Independent t test and Chi-square test.
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(78.4%) in the control group. The patients’ age, gender, and
grade of hospitalization institutes did not differ noticeably
between the two groups, and most of them chose medical
centers and their affiliated hospices for end-of-life hospitali-
zation. The hospice-care group had significantly shorter
hospital stays and lower daily/total charges of hospitalization,
including the daily costs of laboratory examinations, radio-
logical examinations, and drug prescriptions compared with
the control group ( p< 0.05; Table 1).
The admission departments for patients’ end-of-life hospi-
talization are listed in Table 2, and their distributions can be
seen to be significantly different ( p< 0.001). The hospice-
care group had an apparently higher ratio of care provided
by family medicine and radiation oncology than the control
group. In contrast, the control group had a higher ratio of care
provided by internal medicine and surgery.
Table 3 lists patients’ co-morbidities. The hospice-care
group had significantly higher scores on the Charlson Comor-
bidity Index, more individuals with diabetes mellitus, and
fewer with acute lower respiratory conditions than the control
group ( p< 0.05). No CPR, defibrillation/cardioversion, endo-
tracheal intubation, tracheostomy, hemodialysis, ICU admis-
sions, or respirator care was performed with the hospice-care
group. The hospice-care group had significantly fewer invasive
procedures than the control group ( p< 0.001 for all; Table 4).Table 2
Departments of admission of end-of-life hospitalizations in elderly lung cancer
patients in 2004.a
Admission Sections Hospice-care
group n¼ 277 (%)
Control group
n¼ 1005 (%)
Family medicine 114 (41.2) 48 (4.8)
Internal medicine 120 (43.3) 869 (86.5)
Surgery 2 (0.7) 36 (3.6)
Orthopedics 0 (0) 2 (0.2)
Neurological surgery 0 (0) 7 (0.7)
Neurological medicine 3 (1.1) 6 (0.6)
Emergent medicine 0 (0) 1 (0.1)
Radiation oncology 38 (13.7) 36 (3.6)
a Trend Chi-square test, p< 0.001.In terms of prescriptions, natural opium alkaloids (ATC
code N02AA) were the most commonly ordered prescriptions
in the hospital-care group, whereas parenteral electrolyte
solutions (ATC code B05BB) were more common in the
control group. Analgesics (ATC code N02AA, M01AB),
parenteral solutions (ATC code B05BB), steroids (ATC code
H02AB), benzodiazepines (ATC code N05CD, N02BA),
gastrointestinal kinetic or laxative agents (ATC code A06AB,
A03FA, A02AA), drugs for respiratory care (ATC code
R03AC, R05CB), and cephalosporin (ATC code J01DA) were
the major components of prescriptions in hospice-care group
(Table 5).
4. Discussion
In Taiwan, relevant local studies have highlighted some
advantages of hospice care, including reduced medical costs
and promoting satisfaction for terminal patients and their
families.10 Local patients under palliative care tended to stay
in wards instead of receiving care at home.11 In this claim-
based study, the advantages of hospice care have been
proven once again, such as short hospital stays and low daily/
total costs for the end-of-life hospitalizations in contrast to the
control group (acute ward care). Besides, the differences in
payment policy also led to savings on medical resources in
hospice care. In the NHI of Taiwan, hospice care involved
fixed payment for services, while general ward care involved
fee-for-service. The low daily costs of laboratory examina-
tions, radiological examinations, and drug prescriptions reflect
the impact of fixed payment on medical behaviors, and it is
beneficial to distribute limited or expensive medical resources.
Similar financial benefits have also been reported in Spain and
the United States.12,13
It is interesting to note that most patients in the hospice-
care group chose medical centers for their end-of-life hospi-
talization (163 of 277 patients, 58.8%). This phenomenon is
associated with the characteristics of the medical systems and
patients’ attitudes in Taiwan. In the West, hospices are usually
independent institutions and receive referrals from general
hospitals. In contrast, most hospices in Taiwan are affiliated
with general hospitals.14 In the United States, patients referred
Table 3
Comparison of patient co-morbidities between elderly lung cancer patients receiving and not receiving hospice care during 2004.
Hospice-care group n¼ 277 (%) Control group n¼ 1005 (%) pa
Diabetes mellitus 38 (13.7) 89 (8.9) 0.023
Stroke 8 (2.9) 37 (3.7) 0.712
Chronic obstructive pulmonary disease 27 (9.7) 141 (14.0) 0.070
Ischemic heart disease 10 (3.6) 49 (4.9) 0.422
Acute lower respiratory conditions 40 (14.4) 316 (31.4) < 0.001
Charlson Comorbidity Index 6.8 2.7 6.0 3.0 < 0.001
a Independent t test, Chi-square and Fisher’s exact tests.
224 S.-C. Kang et al. / Journal of the Chinese Medical Association 75 (2012) 221e226from academic medical centers needed more medical and
nursing services when admitted to a hospice.15 Predominantly,
admissions to medical center-affiliated hospices reflected the
patients’ and/or families’ confidence in medical care, but also
are identified as being at least partially responsible for the
underlying waste of medical resources. Within this area,
however, relevant issues and patients’/families’ concepts as
they relate to terminal cancer care need further research.
The ultimate decision regarding patients’ choice for end-of-
life hospitalization reflected the noticeable roles of family
physicians and radiation oncologists in hospice care in
Taiwan. Patient experiences in the United States and France
also revealed similar roles of family physicians and general
practitioners in hospice care.16,17 In contrast, some studies
indicate conservative views on this issue.18,19 In particular,
radiation oncologists perform an important role in inpatient
hospice care in Taiwan. In 1990, the first hospice in Taiwan
was created by radiation oncologists, which has since become
the model for the rest of Taiwan hospices.20 The participation
of different specialists in hospice care, such as family physi-
cians, internal physicians, medical oncologists, and radiation
oncologists, needs to be considered for further research and in
order t establish a comparison with different countries or
cultures.
It should be noted that internal physicians (including rele-
vant specialists) still cared for the majority of elderly patients
with lung cancer during their end-of-life hospitalization in
both the hospice-care and control groups (43.3 vs 86.5%,
respectively). Traditionally, internal physicians and surgeons
have been trained to take acute and critical care for granted.Table 4
Comparison of invasive procedures between elderly lung cancer patients receiving
Hospice-care group n¼ 277 (
Cardiopulmonary resuscitation 0 (0)
Defibrillation or cardioversion 0 (0)
Endotracheal intubation 0 (0)
Tracheostomy 0 (0)
Chest tapping or intubation 5 (1.8)
Nasogastric intubation 38 (13.7)
Urinary catheterization 101 (36.5)
Central venous catheter insertion 13 (4.7)
Hemodialysis 0 (0)
Intensive care unit admission 0 (0)
Respirator care 0 (0)
a Chi-square and Fisher’s exact tests.Consequently, there are still opportunities to educate and
modify the perception, working concepts, and role of hospice
care for these groups.
The minor role of invasive or aggressive procedures is
compatible with the principles of hospice care, such as
avoidance of CPR, defibrillation/cardioversion, endotracheal
intubation, tracheostomy, and respirator care. In contrast, the
control group (acute ward care) still widely received invasive
procedures, especially ICU admissions and respirator care,
although over two-thirds of the control-group patients were
not resuscitated at the end of life. Reducing unnecessary
invasive procedures should be an important issue when
considering whether a patient should receive palliative care.
Therapeutic roles related to co-morbid diabetes mellitus
were interesting and difficult in terms of patients with
advanced cancer. The complications of advanced cancer, such
as poor appetite, nausea/vomiting, and the use of steroids all
make blood sugar levels difficult to control.21,22 There is still
no therapeutic guideline on diabetes mellitus for those with
advanced cancer.23 Our results showed a relatively high ratio
of co-morbid diabetes mellitus in the hospice-care group, and
the therapeutic challenges need to be further investigated in
hospice patients.
The predominance of acute lower respiratory conditions in
the control group (up to 31.4%) reflected the indications of
acute ward care. The control group also had a higher ratio of
chronic obstructive pulmonary disease, although this was not
statistically significant. These characteristics could explain the
distribution of prescriptions in Table 5. Compared with the
hospice-care group, patients under acute ward care wereand not receiving hospice care during 2004.
%) Control group n¼ 1005 (%) pa
168 (16.7) < 0.001
33 (3.3%) < 0.001
287 (28.6) < 0.001
16 (1.6%) < 0.001
342 (34.0) < 0.001
856 (85.6) < 0.001
775 (77.1) < 0.001
287 (28.6) < 0.001
25 (2.5%) < 0.001
353 (35.1%) < 0.001
430 (42.8%) < 0.001
Table 5
The top 12 prescribed drugs in end-of-life hospitalization of elderly lung cancer patients receiving and not receiving hospice care during 2004.
Ranking Hospice-care group
(ATC code, number, and % of patients receiving the drug) (N¼ 277)
Control group
(ATC code, number, and % of patients receiving the drug) (N¼ 1005)
1 Natural opium alkaloids a (N02AA, n¼ 226, 81.6 %) Solutions affecting electrolyte balance (B05BB, n¼ 966, 96.1%)
2 Solutions affecting electrolyte balance (B05BB, n¼ 220, 79.4%) Contact laxatives (A06AB, n¼ 670, 66.7%)
3 Glucocorticoids (H02AB, n¼ 184, 66.4%) Solutions for parenteral nutrition (B05BA, n¼ 642, 63.9%)
4 Benzodiazepine derivatives (N05CD, n¼ 162, 58.5%) Sulfonamide plain diuretics (C03CA, n¼ 638, 63.5%)
5 Contact laxatives (A06AB, n¼ 161, 58.1%) Glucocorticoids (H02AB, n¼ 626, 62.3%)
6 Magnesium compounds (A02AA, n¼ 147, 53.1%) Magnesium compounds (A02AA, n¼ 595, 59.2%)
7 Propulsives (A03FA, n¼ 127, 45.8%) Adrenergic and dopaminergic agents (C01CA, n¼ 593, 59.0%)
8 Mucolytics (R05CB, n¼ 109, 39.4%) Cephalosporins (J01DA, n¼ 593, 59.0%)
9 Beta-2 adrenoceptor agonists (R03AC, n¼ 104, 37.5%) Electrolyte solutions (B05XA, n¼ 576, 57.3%)
10 Cephalosporins (J01DA, n¼ 102, 36.8%) Antiasthmatics/anticholinergics (R03BB, n¼ 567, 56.4%)
11 Benzodiazepines (N02BA, n¼ 100, 36.1%) Beta-2 adrenoceptor agonists (R03AC, n¼ 548, 54.5%)
12 Acetic acid derivatives (M01AB, n¼ 91, 32.9%) Propulsives (A03FA, n¼ 548, 54.5%)
ATC¼Anatomic Therapeutic Chemical Classification.
a In the control group, the prescriptions of natural opium alkaloids covered 371 patients (36.9% of the control group).
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supplements (ATC code B05BA, B05XA), diuretics (ATC
code C03CA), adrenergic/dopaminergic agents (ATC code
C01CA), and antiasthmatics/anticholinergics (ATC code
R03BB). The coverage of opioids (ATC code N02AA) was
much lower in the control group. The prescriptions for the
control (acute ward care) group were aimed at nutritional
support, maintaining blood pressure, and controlling respira-
tory problems or fluid overload. Pain control should be
promoted for patients with advanced cancer, even under acute
ward care.
The wide use of bronchodilators (ATC code R03BB,
R03AC) in the control group reflected paradoxical views
related to dyspnea in end-of-life patients with lung cancer. For
instance, over half the control group used beta-2 adrenoceptor
agonists, whereas only 37.5% of the hospice-care group did.
Document reviews have proven the advantages of using
opioids for the control of cancer-related dyspnea instead of
bronchodilators.24,25 Hospice care has been proven to reduce
unnecessary prescriptions and save resources for elderly
patients.26 Opioids have their place in promoting the relief of
dyspnea in acute ward care.
Parenteral nutrition/hydration also reflected paradoxical
issues for hospice care in Taiwan. Up to 79.4% of the hospice-
care group received parenteral hydration (ATC code B05BB).
Furthermore, parenteral nutrition and electrolyte supplements
(ATC code B05BA, B05XA) were given almost to those under
end-of-life acute ward care. Although parenteral nutrition/
hydration had few benefits for terminal patients, 27 inaccurate
beliefs still existed among terminal patients and their families
in Taiwan.28,29 The use of parenteral nutrition/hydration
requires rigorous guidelines.30
The role of antibiotics in terminal cancer patients is inter-
esting. For ICU care, the continuous use of antibiotics for
terminal patients had no benefit because of the development
of resistant strains and nosocomial infections.31 The use of
antibiotics in hospice care should be imposed for the control of
symptoms.32 In this study, the prescription of cephalosporin
(ATC code J01DA) still covered 36.8% of the hospice-caregroup. A further reduction of any unnecessary use of antibi-
otics should be aggressively promoted.
It should be noted that both groups had a very substantial
number of prescriptions for constipation, possibly correlated
with the use of opioids. Optimal dose adjustments may be
considered to reduce side effects under good pain control.33 In
addition, re only 21.6% of enrolled elderly patients with lung
cancer were undergoing hospice care at their end-of-life
hospitalization. This ratio is lower than in the United
Kingdom (36%), Spain (25e50%) and Norway (26%;
including nursing home care), but higher than in Ireland (12%;
16% if including nursing home care).34e37 Hospice care still
has room to promote itself and expand in Taiwan.
The design of our study had, however, some limitations.
Focussing on elderly patients with lung cancer limited the
investigation of other cancers and different age groups.
Screening with ICD-9-CM codes may have some limitations
of accuracy, underestimating the actual prevalence of co-
morbidities without the ability to clearly identify patholog-
ical types and stages of lung cancer. Out-of-hospital deaths,
including dying at home and discharge with critical condi-
tions, could not be considered in this study concerning end-of-
life hospitalization. In addition, the role of psychological and
spiritual therapies in hospice care could not be evaluated due
to the limited data. Further studies on hospice care and its
impact on medical systems are indicated in Taiwan.
In conclusion, hospice care has made an impact on elderly
patients with lung cancer. The experiences of hospice care
patients, however, have been different from those of patients in
acute ward care, such as shorter hospital stays, reduced cost of
stays, and fewer invasive procedures. The distributions of co-
morbidities and common prescriptions were quite different
between the two groups. From experiences in Taiwan, opioids
should be promoted for the control of dyspnea, and the use of
parenteral nutrition/hydration and antibiotics should be
reduced in hospice care. Hospice care provides an economic
advantage in caring for elderly patients with lung cancer at the
end of their lives. Family physicians and radiation oncologists
both perform an important role in hospice care. Ultimately,
226 S.-C. Kang et al. / Journal of the Chinese Medical Association 75 (2012) 221e226compared with prevalence of hospice care in the United
Kingdom and other developed countries, there is still an
opportunity to improve hospice care in Taiwan.Acknowledgments
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